These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36200246)

  • 1. Compelling Cyclic Peptide Scaffolds for Antitubercular Action: An Account (2011-21) of the Natural Source.
    Chowdhury A; Bandyopadhyay A
    Curr Protein Pept Sci; 2022; 23(12):823-836. PubMed ID: 36200246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities.
    Barbie P; Kazmaier U
    Org Biomol Chem; 2016 Jul; 14(25):6036-54. PubMed ID: 27241518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin.
    Hawkins PME; Tran W; Nagalingam G; Cheung CY; Giltrap AM; Cook GM; Britton WJ; Payne RJ
    Chemistry; 2020 Nov; 26(66):15200-15205. PubMed ID: 32567168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.
    Gao W; Kim JY; Anderson JR; Akopian T; Hong S; Jin YY; Kandror O; Kim JW; Lee IA; Lee SY; McAlpine JB; Mulugeta S; Sunoqrot S; Wang Y; Yang SH; Yoon TM; Goldberg AL; Pauli GF; Suh JW; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):880-9. PubMed ID: 25421483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.
    Cazzaniga G; Mori M; Chiarelli LR; Gelain A; Meneghetti F; Villa S
    Eur J Med Chem; 2021 Nov; 224():113732. PubMed ID: 34399099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in natural product-based drug discovery for tuberculosis.
    Dong M; Pfeiffer B; Altmann KH
    Drug Discov Today; 2017 Mar; 22(3):585-591. PubMed ID: 27890820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Proline-Rich Cyclopolypeptides from Marine Organisms: Chemistry, Synthetic Methodologies and Biological Status.
    Fang WY; Dahiya R; Qin HL; Mourya R; Maharaj S
    Mar Drugs; 2016 Oct; 14(11):. PubMed ID: 27792168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassomycin and lariatin lasso peptides as suitable antibiotics for combating mycobacterial infections: current state of biosynthesis and perspectives for production.
    Zhu S; Su Y; Shams S; Feng Y; Tong Y; Zheng G
    Appl Microbiol Biotechnol; 2019 May; 103(10):3931-3940. PubMed ID: 30915503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
    Kling A; Lukat P; Almeida DV; Bauer A; Fontaine E; Sordello S; Zaburannyi N; Herrmann J; Wenzel SC; König C; Ammerman NC; Barrio MB; Borchers K; Bordon-Pallier F; Brönstrup M; Courtemanche G; Gerlitz M; Geslin M; Hammann P; Heinz DW; Hoffmann H; Klieber S; Kohlmann M; Kurz M; Lair C; Matter H; Nuermberger E; Tyagi S; Fraisse L; Grosset JH; Lagrange S; Müller R
    Science; 2015 Jun; 348(6239):1106-12. PubMed ID: 26045430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.
    Singh SB; Xu L; Meinke PT; Kurepina N; Kreiswirth BN; Olsen DB; Young K
    J Antibiot (Tokyo); 2017 May; 70(5):671-674. PubMed ID: 28096545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-Phase Synthesis of Wollamide Cyclohexapeptide Analogs.
    Prior AM; Sun D
    Methods Mol Biol; 2020; 2103():175-187. PubMed ID: 31879925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in antitubercular natural products.
    García A; Bocanegra-García V; Palma-Nicolás JP; Rivera G
    Eur J Med Chem; 2012 Mar; 49():1-23. PubMed ID: 22280816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recently disclosed chemical entities as potential candidates for management of tuberculosis.
    Stec J; Abourashed EA
    Pharm Pat Anal; 2015; 4(4):317-47. PubMed ID: 26174569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
    Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
    Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and revisited approaches in antituberculosis drug discovery.
    Herrmann J; Rybniker J; Müller R
    Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets.
    Oh S; Trifonov L; Yadav VD; Barry CE; Boshoff HI
    Front Cell Infect Microbiol; 2021; 11():611304. PubMed ID: 33791235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity.
    Yathursan S; Wiles S; Read H; Sarojini V
    J Pept Sci; 2019 Nov; 25(11):e3213. PubMed ID: 31515916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D; McHugh TD
    Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.